TRANSRADIAL UFE WITH HYDROPEARL® MICROSPHERES

Uterine Fibroids account for 30% of the 600,000 women who undergo hysterectomies annually.1 Uterine fibroid embolization (UFE) is a minimally-invasive alternative to hysterectomy or myomectomy.

TransRadial Artery Access (TRA) is proven to reduce associated bleeding and vascular complications. Using TRA in embolization procedures conveys proven benefits such as same day discharge opportunities, reduction in major bleeding complications, a readily accessible and easy to manage access site, and improved patient satisfaction.2-5

Terumo Interventional Systems is equipped to support your UFE procedures from access to embolization to closure.

HYDROPEARL MICROSPHERES FOR UTERINE FIBROID EMBOLIZATION

Keep your patients in mind as you embolize. The unique formulation of HydroPearl Microspheres was exclusively developed to offer controlled and targeted embolization. HydroPearl Microspheres are tightly calibrated and indicated for embolization of uterine fibroids. This precise calibration may allow more predictable and targeted embolization.6-8 Watch the video below to see how the precise engineering of HydroPearl can make a difference in your procedures:

 

Click here to learn more about the other benefits of HydroPearl for your embolization procedures.

Explore comprehensive access and closure options to guide your approach to uterine artery embolization

Terumo Interventional Systems is the pioneer in radial access with customized solutions that deliver economic value for providers and enhanced outcomes for their patients. 

Learn more about Terumo's full portfolio of embolization solutions

Advancing Clinical Education

Terumo Learning EDGE™ has procedural training that will help you advance your practice and optimize patient outcomes. Learn more about our offerings for TransRadial Uterine Fibroid Embolization.

EMBOLIZATION TREATMENT FOR WOMEN'S HEALTH

CLINICAL RESOURCES FOR TRANSRADIAL UTERINE ARTERY EMBOLIZATION

REFERENCES

  1. SIR Foundation. https://www.sirweb.org/globalassets/aasociety-of-interventional-radiology-home-page/patient-center/fibroid/sir_report_final.pdf. Accessed on 7 May 2020.
  2. Schussler JM. Effectiveness and safety of transradial artery access for cardiac catheterization. Proc (Bayl Univ Med Cent). 2011; 24(3):205-209.
  3. Marso SP, et al. National Cardiovascular Data Registry. Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention. JAMA. 2010 Jun 2;303(21):2156-64. doi: 10.1001/jama.2010.708. PMID: 20516416.
  4. Duffin DC, Muhlestein JB, Allisson SB, et al. Femoral arterial puncture management after percutaneous coronary procedures: a comparison of clinical outcomes and patient satisfaction between manual compression and two different vascular closure devices. J Invasive Cardiol. 2001;13(5):354-362.
  5. Valgimigli M, et al. MATRIX Trial. Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomized multicenter trial. Lancet. 2015;385:2465-76.
  6. HydroPearl IFU (PD111835 Rev B), 2020-02.
  7. Data on file.
  8. Karolin J. Paprottka et al In-vitro-study of physical properties of various embolization particles regarding morphology before, during and after catheter passage. Clinical Hemorheology and Microcirculation. 1386-0291/16.    

DOCUMENTS

HydroPearl Brochure
Radial Case Planning Form